Real-world rates and risk factors for subsequent treatment with vertebroplasty or balloon kyphoplasty after initial vertebral augmentation: a retrospective cohort study
Osteoporosis International · 2025
DOI: 10.1007/s00198-024-07294-z ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Osteoporosis International, 2025. Verfasst von Joshua A Hirsch und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Neuroradiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA. jahirsch@mgh.harvard.…. Hauptthemen laut MEDLINE: Kyphoplasty, Spinal Fractures, Osteoporotic Fractures, Vertebroplasty. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The purpose of this study was to determine the real-world incidence and predictors of additional vertebroplasty or balloon kyphoplasty after initial vertebral augmentation, as a proxy for subsequent symptomatic vertebral fracture. Of patients, 15.5% underwent subsequent vertebral augmentation. The patient's comorbidities are strongly associated with risk of subsequent treatment. PURPOSE: To determine the real-world incidence and predictors of additional vertebroplasty or balloon kyphoplasty after initial vertebral augmentation, as a proxy for subsequent symptomatic and disabling vertebral fracture. METHODS: We conducted a retrospective cohort study using commercial insurance claims data (Optum's de-identified Clinformatics® Data Mart Database). Adult patients who underwent subsequent treatment for vertebral fracture within 24 months of initial balloon kyphoplasty (BKP) or vertebroplasty (VP) were classified into "subsequent treatment" or "no subsequent treatment" cohorts. Survival analysis was applied to investigate the effect of risk factors on subsequent treatment. RESULTS: Between 1 January 2008 and 30 June 2020, a total of 32,513 adult patients underwent a BKP/VP procedure following a diagnosis of vertebral compression fracture in the preceding 12 months. Five thousand thirty-five patients (15.5%) underwent a subsequent BKP/VP treatment within 2 years; 90% had a single fracture level treated. An increased hazard of subsequent treatment was associated with a number of fractures treated at initial BKP/VP (≥ 4 levels, adjusted hazard ratio (AHR) 1.68 (95% CI 1.24-2.26); steroid use, AHR 1.9 (95% CI 1.31-1.48); Elixhauser Comorbidity Index ≥ 4, AHR 1.44 (95% CI 1.17-1.77); and multiple myeloma, AHR 1.31 (95% CI 1.13-1.53)). Age < 70 years was associated with reduced hazard of subsequent treatment (AHR 0.81, 95% CI 0.74-0.89). CONCLUSIONS: One in seven patients underwent subsequent treatment for vertebral fracture after initial vertebral augmentation. Baseline patient characteristics were associated with increased risk of subsequent fracture within 2 years, suggesting that a patient's natural history is strongly associated with risk of subsequent treatment rather than the initial surgical procedure itself.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Interventional Neuroradiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA. jahirsch@mgh.harvard.edu.
- Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA. jahirsch@mgh.harvard.edu.
- Office of the Chief Medical and Quality Officer, Robert Wood Johnson University Hospital, New Brunswick, NJ, USA.
- Department of Interventional Neuroradiology, Monash Medical Centre and Monash University, Melbourne, Australia.
- Department of Radiology, Montefiore Medical Center, Bronx, NY, USA.
- Medtronic, Plc, Minneapolis, MN, USA.
Zitieren
APA
Hirsch, J. A., Gilligan, C., Chandra, R. V., Brook, A., Gasquet, N. C., Ricker, C. N., & Wu, C. (2025). Real-world rates and risk factors for subsequent treatment with vertebroplasty or balloon kyphoplasty after initial vertebral augmentation: a retrospective cohort study. Osteoporosis International. https://doi.org/10.1007/s00198-024-07294-z
Vancouver
Hirsch JA, Gilligan C, Chandra RV, Brook A, Gasquet NC, Ricker CN, et al. Real-world rates and risk factors for subsequent treatment with vertebroplasty or balloon kyphoplasty after initial vertebral augmentation: a retrospective cohort study. Osteoporosis International. 2025. doi:10.1007/s00198-024-07294-z
BibTeX
@article{Hirsch2025,
author = {Hirsch, Joshua A and Gilligan, Christopher and Chandra, Ronil V and Brook, Allan and Gasquet, Nicolas C and Ricker, Christine N and Wu, Charlotte},
title = {Real-world rates and risk factors for subsequent treatment with vertebroplasty or balloon kyphoplasty after initial vertebral augmentation: a retrospective cohort study},
journal = {Osteoporosis International},
year = {2025},
doi = {10.1007/s00198-024-07294-z}
}
EUVIMED